Robert Casey actually said...

We are happy the Inflation Reduction Act got those costs down for Medicare Part D beneficiaries.

It will be a huge issue among many difficult issues in this reauthorization.

We need it and we need notification both with drugs and devices.

We learned a horrible lesson in the pandemic, which--and the way I look at it, kind of a national failure when we couldn't provide the kind ...